InsightRX
  • For Providers
    • Solutions
      • MIPD for Providers Explore our full solution for Bayesian model-informed dosing
      • Future of Pharmacy Learn what's next for AI in health tech, and why architecture matters
    • Products
      • InsightRX Nova Bayesian dosing (MIPD) app for bedside clinical decision support
      • InsightRX Apollo Real-time clinical analytics to measure outcomes
      • Drug Modules Available medications for precision dosing apps
  • For Life Sciences
    • Overview
      • InsightRX for Life Sciences Explore our solution for biopharma and clinical trial use
    • Products
      • Nova for Life Sciences Precision dosing app for clinical trial use
      • Astra for Life Sciences AI-native environment for PK/PD modeling and simulation
  • Platform
    • Continuous Learning Patented process for model retraining and improvement
    • Integrations Platform interoperability setup with EHRs, EDCs, and more
    • Security & Regulatory Standards for product development and release
    • Success & Support Pharmacist-led training, onboarding, and education
  • Resources
    • Science
      • Data Science Explore the science and learn more about our R&D
      • Scientific Publications Impactful research manuscripts with at least one InsightRX author
      • How to Cite Using one of our apps? Follow this easy guide for citation in research
    • Explore
      • Success Stories Case studies from real InsightRX customers about their journey
      • White Papers In-depth analysis and best practices for review and download
      • Pubs. Using InsightRX Review research that has used InsightRX applications
    • Blog
      • All Blog Posts Read the latest posts by our team of experts
      • Product Innovation The latest updates on our products, services, and science
      • Thought Leadership Posts from our team of experts on PK, MIPD, science, and more
  • Company
    • About
      • About Us Our story, what drives us and why we're passionate about our work
      • Leadership Founders and team leaders who strive toward excellence in MIPD
      • Advisory Board Scientists and experts to ensure our collective success
      • Careers Interested in joining? View available openings here
      • Customers Hear what others have to say about their experience
    • News
      • All News All company updates, announcements, and media coverage
      • Press Releases Announcements for events, partnerships, and company updates
      • Media InsightRX in digital, print, and podcast coverage
Contact Us
Contact Us
  1. Home
  2. Resources
  3. Blog

InsightRX Blog

Resources, analysis, and commentary on model-informed precision dosing, from the clinicians and scientists doing the work.
Thought Leadership Jun 10, 2026

From Computational Models to Agentic Clinical AI

Thought Leadership Feb 10, 2026

From Chatbots to Bedside-Ready AI Systems

Thought Leadership Dec 11, 2025

Beyond the Hype: A Pragmatic Look at Machine Learning for Precision Dosing

Product Innovation Sep 11, 2024

Choosing the right model for your patient: An introduction to InsightRX Gemini

Thought Leadership Feb 27, 2024

Artificial Intelligence Drives Industry Response to Project Optimus

Thought Leadership Oct 12, 2023

Using hybrid PKPD/ML models to accurately predict risk of neutropenia

Thought Leadership Feb 28, 2023

What Does 2023 Hold for Biopharma? Part 5: Technological Advances

Thought Leadership Jan 3, 2023

The 2023 PharmaVoice Crystal Ball: Peering into the future of life sciences

Thought Leadership Dec 16, 2022

What to Expect from AI-Enabled Drug Discovery in 2023

Maximize therapeutic success
with precision medicine.

Contact Us

What We Do

For Providers
  • Nova (Bayesian Dosing)
  • Apollo (Clinical Analytics)
  • Drug Modules
For Life Sciences
  • Nova (MIPD for Clinical Trials)
  • Astra (AI-Powered Clin Pharm)
  • Companion Applications

How We Do It

Platform
  • Continuous Learning
  • Integrations
  • Security & Regulatory
  • Success & Support
Science
  • Data Science
  • Scientific Publications

Information

Resources
  • Success Stories
  • White Papers
  • Publications Using InsightRX
  • How to Cite InsightRX
Blog
  • All Posts
  • Product Innovation
  • Thought Leadership

Company

  • Our Story
  • Leadership
  • Advisory Board
  • Our Customers
  • Press Releases
  • Media
  • Events
  • Careers
  • Contact

CE marking

InsightRX Nova is HITRUST CSF r2 certified, CE marked, and 21 CFR Part 11 compliant. Our quality management, risk management, software lifecycle, and usability engineering processes conform to ISO 13485, IEC 62304, ISO 14971, IEC 62366-1, and IEC 82304-1.

InsightRX Nova is not considered to be a medical device in the U.S. and has not been submitted to the U.S. Food and Drug Administration for review or clearance.

740-05000-REC-01 · 08/2025


InsightRX
548 Market Street
#88083
San Francisco, CA 94104

© 2026 InsightRX, Inc. All rights reserved.
Privacy Policy Cookie Preferences